Hermona Soreq | Academic Influence

Hermona Soreq's AcademicInfluence.com Rankings

Hermona Soreq

Biology

#2710

World Rank

#4271

Historical Rank

Biochemistry

#490

World Rank

#574

Historical Rank

Neuroscience

#578

World Rank

#603

Historical Rank

biology Degrees

Download Badge

Biology

Hermona Soreq's Degrees

PhD Biochemistry Weizmann Institute of Science

Why Is Hermona Soreq Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Hermona Soreq is an Israeli professor of Molecular Neuroscience at The Hebrew University of Jerusalem. Best known for her work on the signaling of acetylcholine and its relevance in stress responses and neurodegenerative diseases such as Parkinson's and Alzheimer's.

(See a Problem?)

Hermona Soreq's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin (1985) (1523)
Differentiation of Human Embryonic Stem Cells into Embryoid Bodies Comprising the Three Embryonic Germ Layers (2000) (1371)
Acetylcholinesterase — new roles for an old actor (2001) (1205)
Function of alternative splicing. (2005) (1150)
Acute stress facilitates long-lasting changes in cholinergic gene expression (1998) (600)
Expression of epidermal growth factor receptors in human brain tumors. (1984) (491)
MicroRNA-132 potentiates cholinergic anti-inflammatory signaling by targeting acetylcholinesterase. (2009) (398)
Alteration of the microRNA network during the progression of Alzheimer's disease (2013) (394)
Pyridostigmine brain penetration under stress enhances neuronal excitability and induces early immediate transcriptional response (1996) (363)
Structural roles of acetylcholinesterase variants in biology and pathology. (1999) (345)
Two interferon mRNAs in human fibroblasts: in vitro translation and Escherichia coli cloning studies. (1980) (321)
Alternative Splicing and Neuritic mRNA Translocation Under Long-Term Neuronal Hypersensitivity (2002) (227)
Acetylcholinesterase Enhances Neurite Growth and Synapse Development through Alternative Contributions of Its Hydrolytic Capacity, Core Protein, and Variable C Termini (1998) (206)
Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewy body diseases. (2000) (204)
Changes in Brain MicroRNAs Contribute to Cholinergic Stress Reactions (2009) (193)
Acetylcholinesterase promotes beta-amyloid plaques in cerebral cortex (2003) (184)
Virtues and woes of AChE alternative splicing in stress-related neuropathologies (2006) (178)
Systemic inflammation impairs microglial Aβ clearance through NLRP3 inflammasome (2019) (170)
Molecular cloning and construction of the coding region for human acetylcholinesterase reveals a G + C-rich attenuating structure. (1990) (169)
Hippocampal microRNA-132 mediates stress-inducible cognitive deficits through its acetylcholinesterase target (2012) (164)
Butyrylcholinesterase attenuates amyloid fibril formation in vitro. (2006) (159)
X inactivation in mammalian testis is correlated with inactive X–specific transcription (1992) (156)
Isolation and characterization of full-length cDNA clones coding for cholinesterase from fetal human tissues. (1987) (155)
Long Non-Coding RNA and Alternative Splicing Modulations in Parkinson's Leukocytes Identified by RNA Sequencing (2014) (155)
NeurimmiRs: microRNAs in the neuroimmune interface. (2011) (155)
Globin mRNA species containing poly(A) segments of different lengths. Their functional stability in Xenopus oocytes. (1976) (153)
CircRNAs in the brain (2017) (150)
Transgenic expression of human acetylcholinesterase induces progressive cognitive deterioration in mice (1995) (141)
Termination and beyond: acetylcholinesterase as a modulator of synaptic transmission (2006) (139)
Excess "read-through" acetylcholinesterase attenuates but the "synaptic" variant intensifies neurodeterioration correlates. (2000) (134)
RACK1 has the nerve to act: Structure meets function in the nervous system (2006) (133)
Cholinergic-associated loss of hnRNP-A/B in Alzheimer's disease impairs cortical splicing and cognitive function in mice (2012) (129)
Stress-induced alternative splicing of acetylcholinesterase results in enhanced fear memory and long-term potentiation (2004) (129)
Interaction of “readthrough” acetylcholinesterase with RACK1 and PKCβII correlates with intensified fear-induced conflict behavior (2002) (125)
The role of readthrough acetylcholinesterase in the pathophysiology of myasthenia gravis (2003) (124)
Acetylcholinesterase/paraoxonase genotype and expression predict anxiety scores in Health, Risk Factors, Exercise Training, and Genetics study. (2004) (123)
Genetic predisposition to adverse consequences of anti–cholinesterases in ‘atypical’ BCHE carriers (1995) (120)
Functional redundancy of acetylcholinesterase and neuroligin in mammalian neuritogenesis. (1998) (119)
Role of the polyadenylate segment in the translation of globin messenger RNA in Xenopus oocytes. (1974) (119)
Antisense oligonucleotide inhibition of acetylcholinesterase gene expression induces progenitor cell expansion and suppresses hematopoietic apoptosis ex vivo. (1994) (115)
Combinatorial Complexity of 5′ Alternative Acetylcholinesterase Transcripts and Protein Products*[boxs] (2004) (114)
Synthesis and localization of plasma proteins in the developing human brain. Integrity of the fetal blood-brain barrier to endogenous proteins of hepatic origin. (1988) (113)
Blood–brain barrier dysfunction–induced inflammatory signaling in brain pathology and epileptogenesis (2012) (112)
17 Polynucleotide Phosphorylase (1982) (111)
Stress-induced epigenetic transcriptional memory of acetylcholinesterase by HDAC4 (2012) (107)
The biosynthesis of biologically active proteins in mRNA-microinjected Xenopus oocytes. (1985) (107)
Transcriptional regulation of erythropoiesis. Fine tuning of combinatorial multi-domain elements. (2002) (104)
Plasminogen activator in the rodent brain (1981) (103)
A Network-Based Method for Predicting Disease-Causing Genes (2009) (102)
Overexpression of Alternative Human Acetylcholinesterase Forms Modulates Process Extensions in Cultured Glioma Cells (1996) (102)
Absence of polyadenylate segment in globin messenger RNA accelerates its degradation in Xenopus oocytes. (1975) (102)
Enhanced Hemicholinium Binding and Attenuated Dendrite Branching in Cognitively Impaired Acetylcholinesterase‐Transgenic Mice (1997) (101)
Cholinergic status modulations in human volunteers under acute inflammation (2007) (99)
Acetylcholinesterase/paraoxonase interactions increase the risk of insecticide‐induced Parkinson's disease (2005) (98)
Acetylcholinesterase inhibitors reduce brain and blood interleukin‐1β production (2005) (98)
Xenopus oocyte microinjection: from gene to protein. (1992) (97)
Small RNA sequencing-microarray analyses in Parkinson leukocytes reveal deep brain stimulation-induced splicing changes that classify brain region transcriptomes (2013) (97)
Changes in readthrough acetylcholinesterase expression modulate amyloid-beta pathology. (2007) (96)
Serum Cholinesterase Activities Distinguish between Stroke Patients and Controls and Predict 12-Month Mortality (2010) (96)
Checks and balances on cholinergic signaling in brain and body function (2015) (96)
Frequent Blood–Brain Barrier Disruption in the Human Cerebral Cortex (2001) (95)
In vitro translation of polyadenylic acid-free rabbit globin messenger RNA. (1974) (95)
Engineering of human cholinesterases explains and predicts diverse consequences of administration of various drugs and poisons. (1995) (94)
ARP, A Peptide Derived from the Stress-Associated Acetylcholinesterase Variant, Has Hematopoietic Growth Promoting Activities (2001) (93)
Anticholinesterases induce multigenic transcriptional feedback response suppressing cholinergic neurotransmission. (1999) (92)
Coamplification of human acetylcholinesterase and butyrylcholinesterase genes in blood cells: correlation with various leukemias and abnormal megakaryocytopoiesis. (1989) (91)
N-Acetylcholinesterase-Induced Apoptosis in Alzheimer's Disease (2008) (91)
miRNA-132 induces hepatic steatosis and hyperlipidaemia by synergistic multitarget suppression (2017) (91)
Probing accessible sites for ribozymes on human acetylcholinesterase RNA. (1997) (89)
Expression of three alternative acetylcholinesterase messenger RNAs in human tumor cell lines of different tissue origins. (1994) (89)
Photocatalytic Reactive Oxygen Species Formation by Semiconductor-Metal Hybrid Nanoparticles. Toward Light-Induced Modulation of Biological Processes. (2016) (88)
A transcription-activating polymorphism in the ACHE promoter associated with acute sensitivity to anti-acetylcholinesterases. (2000) (87)
Defects in pre-mRNA processing as causes of and predisposition to diseases. (2002) (87)
Heterogeneous Nuclear Ribonucleoprotein G Regulates Splice Site Selection by Binding to CC(A/C)-rich Regions in Pre-mRNA* (2009) (86)
TDP-43 regulates the alternative splicing of hnRNP A1 to yield an aggregation-prone variant in amyotrophic lateral sclerosis (2018) (86)
Human Cholinesterases and Anticholinesterases (1993) (86)
Complex regulation of acetylcholinesterase gene expression in human brain tumors (2002) (86)
Pre‐mRNA splicing modulations in senescence (2002) (85)
Cloning and antisense oligodeoxynucleotide inhibition of a human homolog of cdc2 required in hematopoiesis. (1992) (82)
Synaptic and epidermal accumulations of human acetylcholinesterase are encoded by alternative 3'-terminal exons (1995) (81)
The Butyrylcholinesterase K Variant Confers Structurally Derived Risks for Alzheimer Pathology*♦ (2009) (81)
Competing targets of microRNA-608 affect anxiety and hypertension (2014) (80)
SC35 promotes sustainable stress-induced alternative splicing of neuronal acetylcholinesterase mRNA (2005) (80)
Human Osteogenesis Involves Differentiation-Dependent Increases in the Morphogenically Active 3′ Alternative Splicing Variant of Acetylcholinesterase (1999) (79)
Plant-derived human butyrylcholinesterase, but not an organophosphorous-compound hydrolyzing variant thereof, protects rodents against nerve agents (2010) (79)
Expression of a human acetylcholinesterase promoter-reporter construct in developing neuromuscular junctions of Xenopus embryos. (1993) (78)
Identifying subtle interrelated changes in functional gene categories using continuous measures of gene expression (2005) (77)
HUMAN ERYTHROCYTE BUT NOT BRAIN ACETYLCHOLINESTERASE HYDROLYSES HEROIN TO MORPHINE (1999) (77)
Heterogeneous nuclear ribonucleoprotein A1 in health and neurodegenerative disease: From structural insights to post-transcriptional regulatory roles (2013) (76)
De novo amplification within a "silent" human cholinesterase gene in a family subjected to prolonged exposure to organophosphorous insecticides. (1989) (75)
Functional manipulations of acetylcholinesterase splice variants highlight alternative splicing contributions to murine neocortical development. (2005) (75)
Acetylcholinesterase and butyrylcholinesterase genes coamplify in primary ovarian carcinomas. (1990) (75)
A microfluorometric assay for cholinesterases, suitable for multiple kinetic determinations of picomoles of released thiocholine. (1983) (75)
Endotoxin-induced changes in human working and declarative memory associate with cleavage of plasma “readthrough” acetylcholinesterase (2007) (74)
Amplification and Overexpression of the EGF Receptor Gene in Primary Human Glioblastomas (1985) (74)
Acetylcholinesterase-transgenic mice display embryonic modulations in spinal cord choline acetyltransferase and neurexin Ibeta gene expression followed by late-onset neuromotor deterioration. (1997) (74)
Changes in neuronal acetylcholinesterase gene expression and division of labor in honey bee colonies (2001) (74)
Gene–environment interactions in sporadic Parkinson's disease (2006) (74)
Compensatory mechanisms enhance hippocampal acetylcholine release in transgenic mice expressing human acetylcholinesterase (2001) (73)
MicroRNA‐132 Modulates Cholinergic Signaling and Inflammation in Human Inflammatory Bowel Disease: P‐235 YI (2012) (72)
A role for cholinesterases in tumorigenesis? (1991) (72)
The regulatory function of poly(A) and adjacent 3' sequences in translated RNA. (1982) (70)
Synthesis of plasma proteins in fetal, adult, and neoplastic human brain tissue. (1986) (68)
Hydrolytic and Nonenzymatic Functions of Acetylcholinesterase Comodulate Hemopoietic Stress Responses1 (2006) (67)
Antisense prevention of neuronal damages following head injury in mice (2000) (66)
Estrogen-induced creatine kinase in the reproductive system of the immature female rat. (1983) (66)
Transgenic plants as a source for the bioscavenging enzyme, human butyrylcholinesterase. (2010) (65)
CREB regulates AChE-R-induced proliferation of human glioblastoma cells. (2004) (65)
The stress-associated acetylcholinesterase variant AChE-R is expressed in human CD34(+) hematopoietic progenitors and its C-terminal peptide ARP promotes their proliferation. (2002) (65)
NEAT1 is overexpressed in Parkinson’s disease substantia nigra and confers drug-inducible neuroprotection from oxidative stress (2019) (64)
A Parkinson's disease CircRNAs Resource reveals a link between circSLC8A1 and oxidative stress (2020) (63)
Neuronal overexpression of ‘readthrough’ acetylcholinesterase is associated with antisense-suppressible behavioral impairments (2002) (63)
Readenylation of polyadenylate-free globin messenger RNA restores its stability in vivo. (1975) (63)
Runx1/AML1 in leukemia: disrupted association with diverse protein partners. (2002) (61)
Molecular Mechanisms Regulating LPS-Induced Inflammation in the Brain (2016) (60)
Intramolecular relationships in cholinesterases revealed by oocyte expression of site‐directed and natural variants of human BCHE. (1992) (60)
Plasminogen activator in the developing rat cerebellum: biosynthesis and localization in granular neurons. (1983) (58)
Memory deficits correlating with acetylcholinesterase splice shift and amyloid burden in doubly transgenic mice. (2005) (57)
Immature human megakaryocytes produce nuclear-associated acetylcholinesterase. (1997) (57)
microRNAs in nociceptive circuits as predictors of future clinical applications (2013) (57)
Forebrain Deletion of the Vesicular Acetylcholine Transporter Results in Deficits in Executive Function, Metabolic, and RNA Splicing Abnormalities in the Prefrontal Cortex (2013) (57)
Alzheimer's Disease and ncRNAs. (2017) (57)
Acetylcholine‐induced seizure‐like activity and modified cholinergic gene expression in chronically epileptic rats (2008) (57)
Excavations into the active-site gorge of cholinesterases. (1992) (56)
Stress-induced cholinergic signaling promotes inflammation-associated thrombopoiesis. (2006) (56)
Predicted overlapping microRNA regulators of acetylcholine packaging and degradation in neuroinflammation-related disorders (2014) (56)
Excessive Expression of Acetylcholinesterase Impairs Glutamatergic Synaptogenesis in Hippocampal Neurons (2004) (54)
Mapping the human acetylcholinesterase gene to chromosome 7q22 by fluorescent in situ hybridization coupled with selective PCR amplification from a somatic hybrid cell panel and chromosome-sorted DNA libraries. (1992) (53)
Purification and characterization of polynucleotide phosphorylase from Escherichia coli. Probe for the analysis of 3' sequences of RNA. (1977) (53)
Cholinergic involvement and manipulation approaches in multiple system disorders. (2013) (52)
Expression of cholinesterase gene(s) in human brain tissues: translational evidence for multiple mRNA species. (1984) (52)
RECOMMENDATIONS FOR NOMENCLATURE IN CHOLINESTERASES (1992) (52)
Engineering DYRK1A overdosage yields Down syndrome-characteristic cortical splicing aberrations (2010) (51)
Acetylcholinesterase loosens the brain's cholinergic anti-inflammatory response and promotes epileptogenesis (2012) (51)
TREATMENT OF HUMAN MYASTHENIA GRAVIS WITH ORAL ANTISENSE SUPPRESSION OF ACETYLCHOLINESTERASE (2007) (50)
Manipulations of cholinesterase gene expression modulate murine megakaryocytopoiesis in vitro (1990) (49)
Cholinesterases as Biomarkers for Parasympathetic Dysfunction and Inflammation-Related Disease (2014) (49)
Erythropoietin attenuates hyperoxia-induced oxidative stress in the developing rat brain (2010) (49)
Inherited and acquired interactions between ACHE and PON1 polymorphisms modulate plasma acetylcholinesterase and paraoxonase activities (2005) (48)
Predictors for Poststroke Outcomes: The Tel Aviv Brain Acute Stroke Cohort (TABASCO) Study Protocol (2012) (48)
Post-traumatic anxiety associates with failure of the innate immune receptor TLR9 to evade the pro-inflammatory NFκB pathway (2012) (46)
Cholinergic Surveillance over Hippocampal RNA Metabolism and Alzheimer's-Like Pathology (2016) (45)
Global coevolution of human microRNAs and their target genes. (2014) (45)
Polymorphism of Acetylcholinesterase in Discrete Regions of the Developing Human Fetal Brain (1985) (45)
Cytokines and cholinergic signals co-modulate surgical stress-induced changes in mood and memory (2008) (44)
Translation in vitro of carnation mottle virus RNA. Regulatory function of the 3'-region. (1978) (44)
Coding region paraoxonase polymorphisms dictate accentuated neuronal reactions in chronic, sub‐threshold pesticide exposure (2006) (43)
From Brain to Blood: Alternative Splicing Evidence for the Cholinergic Basis of Mammalian Stress Responses (2004) (43)
Readthrough acetylcholinesterase (AChE-R) and regulated necrosis: pharmacological targets for the regulation of ovarian functions? (2015) (43)
Decline in Serum Cholinesterase Activities Predicts 2-Year Major Adverse Cardiac Events (2014) (43)
Population diversity and distinct haplotype frequencies associated with ACHE and BCHE genes of Israeli Jews from trans-Caucasian Georgia and from Europe. (1994) (42)
Biosynthesis and secretion of catalytically active acetylcholinesterase in Xenopus oocytes microinjected with mRNA from rat brain and from Torpedo electric organ. (1982) (42)
Advanced microarray analysis highlights modified neuro-immune signaling in nucleated blood cells from Parkinson's disease patients (2008) (41)
Expression of alternatively terminated unusual human butyrylcholinesterase messenger RNA transcripts, mapping to chromosome 3q26-ter, in nervous system tumors. (1990) (41)
MicroRNA Regulators of Anxiety and Metabolic Disorders. (2016) (41)
MicroRNA modulation of megakaryoblast fate involves cholinergic signaling. (2006) (41)
Anionic site interactions in human butyrylcholinesterase disrupted by two single point mutations. (1990) (40)
Modified testicular expression of stress‐associated “readthrough” acetylcholinesterase predicts male infertility (2001) (40)
Degradation of deadenylated rabbit α-globin mRNA in Xenopus oocytes is associated with its translation (1977) (40)
Antisense inhibition of acetylcholinesterase gene expression causes transient hematopoietic alterations in vivo. (1994) (39)
Antisense Treatment for Myasthenia Gravis (2008) (39)
Expression of recombinant human acetylcholinesterase in transgenic tomato plants. (2001) (39)
Overexpressed Monomeric Human Acetylcholinesterase Induces Subtle Ultrastructural Modifications in Developing Neuromuscular Junctions of Xenopus laevis Embryos (1994) (39)
Alanine-to-threonine substitutions and amyloid diseases: butyrylcholinesterase as a case study. (2010) (39)
Plant‐derived human acetylcholinesterase‐R provides protection from lethal organophosphate poisoning and its chronic aftermath (2007) (38)
In vitro phosphorylation of acetylcholinesterase at non-consensus protein kinase A sites enhances the rate of acetylcholine hydrolysis. (1997) (38)
Dynamic changes in murine forebrain miR-211 expression associate with cholinergic imbalances and epileptiform activity (2017) (38)
Acetylcholinesterase-R increases germ cell apoptosis but enhances sperm motility (2008) (37)
Sensitive autoradiographic quantification of electrophoretically separated proteases. (1981) (37)
Alzheimer's brains show inter-related changes in RNA and lipid metabolism (2017) (37)
Fear and C-reactive protein cosynergize annual pulse increases in healthy adults (2014) (37)
A systems medicine clinical platform for understanding and managing non- communicable diseases. (2014) (36)
The thymic theme of acetylcholinesterase splice variants in myasthenia gravis. (2007) (36)
Human Recombinant Butyrylcholinesterase Purified from the Milk of Transgenic Goats Interacts with Beta-Amyloid Fibrils and Suppresses Their Formation in vitro (2008) (36)
Fluoxetine induces vasodilatation of cerebral arterioles by co-modulating NO/muscarinic signalling (2012) (35)
Atherosclerosis and arteriosclerosis parameters in stroke patients associate with paraoxonase polymorphism and esterase activities (2013) (35)
Plasma acetylcholinesterase activity correlates with intracerebral β-amyloid load. (2013) (35)
Synaptogenesis and myopathy under acetylcholinesterase overexpression (2000) (34)
Cholinesterase-Targeting microRNAs Identified in silico Affect Specific Biological Processes (2011) (33)
Exon Arrays Reveal Alternative Splicing Aberrations in Parkinson’s Disease Leukocytes (2011) (33)
A lncRNA survey finds increases in neuroprotective LINC‐PINT in Parkinson’s disease substantia nigra (2020) (33)
Recognition of messenger RNA in eukaryotic protein synthesis. Equilibrium studies of the interaction between messenger RNA and the initiation factor that binds methionyl-tRNAf. (1979) (33)
Blood-cell-specific acetylcholinesterase splice variations under changing stimuli (2004) (32)
Use of partially phosphorothioated "antisense" oligodeoxynucleotides for sequence-dependent modulation of hematopoiesis in culture. (1994) (32)
Chronic acetylcholinesterase overexpression induces multilevelled aberrations in mouse neuromuscular physiology (2003) (32)
Modulation in the levels and localization of plasminogen activator in differentiating neuroblastoma cells. (1983) (32)
Integrative Transcriptomics Reveals Sexually Dimorphic Control of the Cholinergic/Neurokine Interface in Schizophrenia and Bipolar Disorder (2019) (32)
Enzymatic acylation of histidine to tobacco mosaic virus RNA. (1976) (32)
Stressing hematopoiesis and immunity: an acetylcholinesterase window into nervous and immune system interactions (2012) (32)
Successive organophosphate inhibition and oxime reactivation reveals distinct responses of recombinant human cholinesterase variants. (1995) (31)
Does 3'-terminal poly(A) stabilize human fibroblast interferon mRNA in oocytes of Xenopus laevis? (1978) (31)
AChE and RACK1 Promote the Anti-Inflammatory Properties of Fluoxetine (2014) (31)
Gene Expression Differences in Peripheral Blood of Parkinson’s Disease Patients with Distinct Progression Profiles (2016) (31)
Threshold-independent meta-analysis of Alzheimer's disease transcriptomes shows progressive changes in hippocampal functions, epigenetics and microRNA regulation. (2012) (31)
Pro-apoptotic protein–protein interactions of the extended N-AChE terminus (2009) (31)
Meta-analysis of genetic and environmental Parkinson's disease models reveals a common role of mitochondrial protection pathways (2012) (31)
MicroRNA therapeutics in neurological disease. (2014) (31)
Activation of the Alternative NFκB Pathway Improves Disease Symptoms in a Model of Sjogren's Syndrome (2011) (30)
Current understanding of fear learning and memory in humans and animal models and the value of a linguistic approach for analyzing fear learning and memory in humans (2019) (30)
Modified properties of serum cholinesterases in primary carcinomas (1988) (30)
The role of the read through variant of acetylcholinesterase in anxiogenic effects of predator stress in mice (2008) (30)
Acetylcholinesterase/C terminal binding protein interactions modify Ikaros functions, causing T lymphopenia (2007) (29)
Aspartate‐70 to glycine substitution confers resistance to naturally occurring and synthetic anionic‐site ligands on inovo produced human butyrylcholinesterase (1990) (29)
Translational control of recombinant human acetylcholinesterase accumulation in plants (2007) (29)
Efficient functioning of plant promoters and poly(A) sites in Xenopus oocytes. (1989) (29)
Purification of transgenic plant-derived recombinant human acetylcholinesterase-R. (2005) (29)
Adaptive changes in acetylcholinesterase gene expression as mediators of recovery from chemical and biological insults. (2007) (28)
The Neat Dance of COVID-19: NEAT1, DANCR, and Co-Modulated Cholinergic RNAs Link to Inflammation (2020) (27)
Impaired hippocampal plasticity and errors in cognitive performance in mice with maladaptive AChE splice site selection (2007) (27)
Transgenic inactivation of acetylcholinesterase impairs homeostasis in mouse hippocampal granule cells (2008) (27)
Messenger ribonucleic acid (mRNA) from developing rat cerebellum directs in vitro synthesis of plasma proteins. (1985) (26)
In vivo gene amplification in non-cancerous cells: cholinesterase genes and oncogenes amplify in thrombocytopenia associated with lupus erythematosus. (1992) (26)
Expression and tissue-specific assembly of human butyrylcholine esterase in microinjected Xenopus laevis oocytes. (1989) (26)
Personalized genetics of the cholinergic blockade of neuroinflammation (2017) (25)
Translational activity and functional stability of human fibroblast beta 1 and beta 2 interferon mRNAs lacking 3'-terminal RNA sequences. (1981) (25)
ARP, the cleavable C-terminal peptide of “readthrough” acetylcholinesterase, promotes neuronal development and plasticity (2007) (25)
Cellular Stress Reactions as Putative Cholinergic Links in Alzheimer’s Disease (2005) (25)
RNA-Targeted Suppression of Stress-Induced Allostasis in Primate Spinal Cord Neurons (2005) (25)
Longitudinal Basal Forebrain Degeneration Interacts with TREM2/C3 Biomarkers of Inflammation in Presymptomatic Alzheimer's Disease (2020) (24)
Tracking cholinergic pathways from psychological and chemical stressors to variable neurodeterioration paradigms. (1999) (24)
Initiation of RNA synthesis in isolated nuclei. (1977) (24)
Are the effects of gestational stress on motor development and cerebellar cholinesterase activity mediated prenatally? (1986) (24)
Promoter elements and alternative splicing in the human ACHE gene. (1993) (24)
Chronic cholinergic imbalances promote brain diffusion and transport abnormalities (2006) (23)
Stress‐induced Alternative Splicing Modulations in Brain and Periphery (2008) (23)
Identifying Alternative Hyper-Splicing Signatures in MG-Thymoma by Exon Arrays (2008) (23)
Cholinergic Regulation of hnRNPA2/B1 Translation by M1 Muscarinic Receptors (2016) (23)
A novel isoform of acetylcholinesterase exacerbates photoreceptors death after photic stress. (2007) (23)
Complex host cell responses to antisense suppression of ACHE gene expression. (2001) (23)
Differentiation intensifies the susceptibility of pheochromocytoma cells to antisense oligodeoxynucleotide-dependent suppression of acetylcholinesterase activity. (1997) (23)
Weakened Cholinergic Blockade of Inflammation Associates with Diabetes-Related Depression (2016) (23)
Transgenic engineering of neuromuscular junctions in Xenopus laevis embryos transiently overexpressing key cholinergic proteins. (1994) (23)
Acetylcholinesterase Variants in Alzheimer’s Disease: From Neuroprotection to Programmed Cell Death (2010) (23)
In vivo and in vitro resistance to multiple anticholinesterases in Xenopus laevis tadpoles. (1998) (22)
Expression of muscarinic binding sites in primary human brain tumors. (1984) (22)
Antisense miR-132 blockade via the AChE-R splice variant mitigates cortical inflammation (2017) (22)
Site‐Directed Mutagenesis of Active Site Residues Reveals Plasticity of Human Butyrylcholinesterase in Substrate and Inhibitor Interactions (1994) (22)
Use of synthetic oligodeoxynucleotide probes for the isolation of a human cholinesterase cDNA clone (1986) (22)
Peripheral Site Acetylcholinesterase Blockade Induces RACK1-Associated Neuronal Remodeling (2007) (21)
Modulated splicing‐associated gene expression in P19 cells expressing distinct acetylcholinesterase splice variants (2006) (21)
Recombinant human acetylcholinesterase is secreted from transiently transfected 293 cells as a soluble globular enzyme (1991) (21)
Muscarinic modulations of neuronal anticholinesterase responses. (2005) (21)
Molecular Regulatory Pathways Link Sepsis With Metabolic Syndrome: Non-coding RNA Elements Underlying the Sepsis/Metabolic Cross-Talk (2018) (21)
Cholinesterase Genes: Multileveled Regulation (1990) (20)
Victims of war-Psychoendocrine evidence for the impact of traumatic stress on psychological well-being of adolescents growing up during the Israeli-Palestinian conflict. (2018) (20)
Mutant α-Synuclein Overexpression Induces Stressless Pacemaking in Vagal Motoneurons at Risk in Parkinson's Disease (2017) (20)
Stereotactic injection of microRNA-expressing lentiviruses to the mouse hippocampus ca1 region and assessment of the behavioral outcome. (2013) (20)
Antisense technologies have a future fighting neurodegenerative diseases. (1999) (20)
Human cholinesterase genes localized by hybridization to chromosomes 3 and 16 (1987) (20)
Altered Ontogenesis of Muscarinic Receptors in Agranular Cerebellar Cortex (1982) (19)
Intensify3D: Normalizing signal intensity in large heterogenic image stacks (2018) (19)
Quantum dot labeling of butyrylcholinesterase maintains substrate and inhibitor interactions and cell adherence features. (2011) (19)
Transgenic acetylcholinesterase induces enlargement of murine neuromuscular junctions but leaves spinal cord synapses intact 2 2 Abbreviations: AChE, acetylcholinesterase; ACh, acetylcholine; ATCh, acetylthiocholine; NMJ, neuromuscular junction. (1998) (19)
Further developments with antisense treatment for myasthenia gravis (2012) (19)
Emerging bioinformatics approaches for analysis of NGS-derived coding and non-coding RNAs in neurodegenerative diseases (2014) (19)
Transfer RNA fragments replace microRNA regulators of the cholinergic poststroke immune blockade (2020) (19)
Variations in gene expression during development of the rat cerebellum. (1982) (19)
Murine and human mast cell express acetylcholinesterase (1996) (19)
Amplification of Butyrylcholinesterase and Acetylcholinesterase Genes in Normal and Tumor Tissues: Putative Relationship to Organophosphorous Poisoning (2004) (18)
Chimeric human cholinesterase. Identification of interaction sites responsible for recognition of acetyl- or butyrylcholinesterase-specific ligands. (1993) (18)
Position effect variegations and brain-specific silencing in transgenic mice overexpressing human acetylcholinesterase variants (1998) (18)
Biosynthesis of catalytically active rat testosterone 5 alpha-reductase in microinjected Xenopus oocytes: evidence for tissue-specific differences in translatable mRNA. (1988) (18)
A human acetylcholinesterase gene identified by homology to the Ace region of Drosophila. (1985) (18)
Alternate AChE-R variants facilitate cellular metabolic activity and resistance to genotoxic stress through enolase and RACK1 interactions. (2008) (18)
Review : The Vicious Circle of Stress and Anticholinesterase Responses (1999) (18)
Regulators of cholinergic signaling in disorders of the central nervous system (2021) (18)
Whole transcriptome RNA sequencing data from blood leukocytes derived from Parkinson's disease patients prior to and following deep brain stimulation treatment (2014) (18)
Readthrough acetylcholinesterase (2007) (17)
Butyrylcholinesterase interactions with amylin may protect pancreatic cells in metabolic syndrome (2011) (17)
Neuronal-expressed microRNA-targeted pseudogenes compete with coding genes in the human brain (2017) (17)
Microinjected Xenopus oocytes synthesize active human plasminogen activator. (1981) (17)
What is the role of poly A on eukaryotic messengers (1977) (17)
Whole blood microRNA expression associated with stroke: Results from the Framingham Heart Study (2019) (16)
Deep brain stimulation modulates nonsense-mediated RNA decay in Parkinson’s patients leukocytes (2013) (16)
Barrel cortex VIP/ChAT interneurons suppress sensory responses in vivo (2020) (16)
Secreted proteins in the medium of microinjected Xenopus oocytes are degraded by oocyte proteases (1981) (16)
Deep brain stimulation induces rapidly reversible transcript changes in Parkinson's leucocytes (2012) (16)
Antibodies against acetylcholinesterase and low levels of cholinesterases in a patient with an atypical neuromuscular disorder. (1988) (16)
Overlapping drug interaction sites of human butyrylcholinesterase dissected by site-directed mutagenesis. (1996) (15)
Upregulation of neuronal nicotinic receptor subunits α4, β2, and α7 in transgenic mice overexpressing human acetylcholinesterase (2002) (15)
Molecular dissection of cholinesterase domains responsible for carbamate toxicity. (1993) (15)
Chorionic villus cDNA library displays expression of butyrylcholinesterase: Putative genetic disposition for ecological danger (1991) (15)
Gut feeling: MicroRNA discriminators of the intestinal TLR9–cholinergic links (2015) (15)
Acetylcholinesterase: old questions and new developments (2013) (15)
Chronic cholinergic imbalances promote brain diffusion and transport abnormalities (2005) (15)
Tissue distribution of cholinesterases and anticholinesterases in native and transgenic tomato plants (2004) (15)
Glial responses during epileptogenesis in Mus musculus point to potential therapeutic targets (2018) (14)
Synthetic leader peptide modulates secretion of proteins from microinjected Xenopus oocytes. (1983) (14)
Preclinical and first-in-human evaluation of PRX-105, a PEGylated, plant-derived, recombinant human acetylcholinesterase-R. (2015) (14)
Transcriptome profiling in Parkinson's leukocytes: from early diagnostics to neuroimmune therapeutic prospects. (2016) (14)
Upregulation of neuronal nicotinic receptor subunits alpha4, beta2, and alpha7 in transgenic mice overexpressing human acetylcholinesterase. (2002) (14)
Manipulations of ACHE gene expression suggest non-catalytic involvement of acetylcholinesterase in the functioning of mammalian photoreceptors but not in retinal degeneration. (1999) (14)
Genomic and transcriptional characterization of the human ACHE locus: complex involvement with acquired and inherited diseases. (2000) (14)
Readthrough acetylcholinesterase in inflammation-associated neuropathies. (2007) (14)
Anti-sense approach to anticholinesterase therapeutics. (2000) (14)
Membrane associated cytoplasmic mRNA in Artemia salina; functional and physical changes during development. (1977) (14)
Normal and Atypical Butyrylcholinesterases in Placental Development, Function, and Malfunction (1997) (14)
Genome-Wide MicroRNA Analysis Implicates miR-30b/d in the Etiology of Alopecia Areata. (2017) (13)
Gene mapping on chorionic villi chromosomes by hybridization in situ: localization of cholinesterase cDNA binding sites to chromosomes 3q21, 3q26-ter and 16q21. (1989) (13)
The Stress-Responding miR-132-3p Shows Evolutionarily Conserved Pathway Interactions (2017) (13)
Modified composition of major ontogenetically regulated mRNAs and proteins in the cerebellum of old and of staggerer mice. (1983) (13)
Functional segregation of voltage-activated calcium channels in motoneurons of the dorsal motor nucleus of the vagus. (2015) (13)
Plasminogen activator is enriched in the synaptosomal plasma membranes (1982) (13)
Acetylcholinesterase Modulates Stress-Induced Motor Responses Through Catalytic and Noncatalytic Properties (2006) (13)
A Parkinson’s disease CircRNAs Resource reveals a link between circSLC8A1 and oxidative stress (2020) (13)
Production of EGF‐containing polypeptides in Xenopus oocytes microinjected with submaxillary gland mRNA. (1984) (12)
Expression and in vivo amplification of the human acetylcholinesterase and butyrylcholinesterase genes. (1990) (12)
Cholinergic drug resistance and impaired spatial learning in transgenic mice overexpressing human brain acetylcholinesterase. (1996) (12)
Modulation of hippocampal neuronal resilience during aging by the Hsp70/Hsp90 co‐chaperone STI1 (2020) (12)
CREB Regulates AChER ± Induced Proliferation of Human Glioblastoma Cells 1 (2004) (11)
Cholinotoxic effects on acetylcholinesterase gene expression are associated with brain-region specific alterations in G,C-rich transcripts (1994) (11)
Central and peripheral anti-inflammatory effects of acetylcholinesterase inhibitors (2020) (11)
It All Starts at the Ends: Multifaceted Involvement of C- and N-Terminally Modified Cholinesterases in Alzheimer’s Disease (2010) (11)
Cholinergic excitation induces activity-dependent electrophysiological and transcriptional responses in hippocampal slices (1998) (11)
Cholinoceptive properties of human primordial, preantral, and antral oocytes: In situ hybridization and biochemical evidence for expression of cholinesterase genes (2008) (10)
Cholino‐ncRNAs modulate sex‐specific‐ and age‐related acetylcholine signals (2020) (10)
Pharmaceutical Implications of Sex-Related RNA Divergence in Psychiatric Disorders. (2020) (10)
Acetylcholinesterase as a window onto stress responses (2005) (10)
HP1BP3 expression determines maternal behavior and offspring survival (2016) (10)
Sequence similarities between human acetylcholinesterase and related proteins: putative implications for therapy of anticholinesterase intoxication. (1989) (10)
Human acetylcholinesterase and butyrylcholinesterase are encoded by two distinct genes (1991) (10)
Ameliorating Active Ulcerative Colitis via an Orally Available Toll-Like Receptor-9 Modifier: A Prospective Open-Label, Multicenter Phase II Trial (2016) (10)
Cortical VIP+/ChAT+ interneurons: From genetics to function (2020) (10)
Expression of cholinesterase genes in human oocytes revealed by in-situ hybridization. (1987) (10)
Degranulation of Rat Cerebellum Induces Selective Variations in Gene Expression (1982) (9)
Neuromuscular Therapeutics by RNA‐Targeted Suppression of ACHE Gene Expression (2006) (9)
Labeling Acetyl- and Butyrylcholinesterase Using Semiconductor Nanocrystals for Biological Applications (2013) (9)
Statistically invalid classification of high throughput gene expression data (2013) (9)
Stress - From Molecules to Behavior: A Comprehensive Analysis of the Neurobiology of Stress Responses (2009) (9)
Organophosphate risk of leukemogenesis. (2004) (9)
I. Introduction: Multileveled Regulation of the Human Cholinesterase Genes and Their Protein Products (1990) (8)
MicroRNA-target interactions in neurodegenerative diseases (2015) (8)
Overlapping molecular signatures in Parkinson's patients' leukocytes before and after treatment and in mouse model brain regions. (2013) (8)
Cholinergic Toxicity and the Male Reproductive System (2011) (8)
Novel roles of non-coding brain RNAs in health and disease (2014) (8)
Stress - From Molecules to Behavior (2009) (8)
Testicular amplification and impaired transmission of human butyrylcholinesterase cDNA in transgenic mice. (1994) (8)
Sustained Alzheimer's Amyloid Pathology in Myeloid Differentiation Protein-88-Deficient APPswe/PS1 Mice (2013) (8)
Competing targets of microRNA-608 affect anxiety and hypertension (2014) (8)
Divergent Regulation of Muscarinic Binding Sites and Acetylcholinesterase in Discrete Regions of the Developing Human Fetal Brain (1986) (8)
Similar cation channels mediate protection from cerebellar exitotoxicity by exercise and inheritance (2012) (7)
Cross‐Homologies and Structural Differences Between Human Cholinesterases Revealed by Antibodies Against cDNA‐Produced Human Butyrylcholinesterase Peptides (1988) (7)
Nicotinic stimulation induces Tristetraprolin over-production and attenuates inflammation in muscle. (2012) (7)
ONTOGENIC AND AGRANULATION-INDUCED ALTERATIONS IN CHOLINESTERASES AND IN CHOLINESTERASE mRNA IN THE RODENT CEREBELLUM (1984) (7)
Analyzing alternative splicing data of splice junction arrays from Parkinson patients' leukocytes before and after deep brain stimulation as compared with control donors (2015) (7)
Development of human antibody fragments directed towards synaptic acetylcholinesterase using a semi-synthetic phage display library. (2002) (7)
Mutations and impaired expression in the ACHE and BCHE genes: neurological implications. (1994) (6)
The use of mRNA translationin vitro andin ovo followed by crossed immunoelectrophoretic autoradiography to study the biosynthesis of human cholinesterases (1986) (6)
ROLE OF THE POLYADENYLATE SEGMENT IN THE STABILITY OF EUKARYOTIC MESSENGER RNAs (1979) (6)
Increase in the translatable mRNA for acetylcholine receptor during embryonic development of Torpedo ocellata electric organ (1982) (6)
Early perceptual loss in depression (2007) (6)
Acetylcholinesterase, cholinergic signaling and Parkinson’s disease (2005) (6)
Antisense inhibition of butyrylcholinesterase gene expression predicts adverse hematopoietic consequences to cholinesterase inhibitors (1994) (6)
MicroRNA-132 may be associated with blood pressure and liver steatosis—preliminary observations in obese individuals (2021) (6)
Adaptive Alternative Splicing Correlates with Less Environmental Risk of Parkinsonism (2011) (6)
Coinjection of Xenopus oocytes with cDNA-produced and native mRNAs: a molecular biological approach to the tissue-specific processing of human cholinesterases. (1990) (6)
Rat growth hormone gene: intervening sequences separate the mRNA regions. (1979) (6)
Organophosphate Intoxication: Molecular Consequences, Mechanisms and Solutions (2009) (5)
Expression of acetylcholinesterase gene(s) in the human brain: molecular cloning evidence for cross-homologous sequences. (1985) (5)
32) Characterizing pea acetylcholinesterase (2005) (5)
Cholinergic blockade of neuroinflammation: from tissue to RNA regulators (2022) (5)
Non-coding RNA regulators of diabetic polyneuropathy (2020) (5)
Acetylcholinesterase Activity in Veterans of the First Gulf War (2007) (5)
Human Cholinesterases from Plants for Detoxification (2004) (5)
Blood acetylcholinesterase activity is associated with increased 10 year all-cause mortality following coronary angiography. (2020) (5)
Serum Cholinesterase Activities as Biomarkers of Cardiac Malfunctioning (2015) (5)
Biosynthesis of acetylcholinesterase in rat brain and Torpedo electric organ is directed by scarce mRNA species. (1983) (4)
The Human Affectome (2022) (4)
The structural basis of amyloid formation. (2008) (4)
Stress-inducible phosphoprotein 1 (HOP/STI1/STIP1) regulates the accumulation and toxicity of α-synuclein in vivo (2022) (4)
Characterizing pea acetylcholinesterase. (2005) (4)
Molecular cloning and construction of the coding region for human acetylcholinesterase reveals a G + Crich attenuating structure ( butyrylcholinesterase / DNA secondary structure / gene amplification / attenuator sequence ) (4)
trans activation of rat phosphoenolpyruvate carboxykinase (GTP) gene expression by micro-coinjection of rat liver mRNA in Xenopus laevis oocytes (1989) (4)
Blood-Brain Barrier Modulations and Low- Level Exposure to Xenobiotics (2000) (4)
Molecular Biology Approach to the Expression and Properties of Mammalian Cholinesterases (1987) (4)
Ethics, public policy and behavioral genetics. (2003) (4)
Testicular Gene Amplification and Impaired BCHE Transcription Induced in Transgenic Mice by the Human BCHE Coding Sequence (1992) (4)
Chromosomal and environmental contributions to sex differences in the vulnerability to neurological and neuropsychiatric disorders: Implications for therapeutic interventions (2022) (4)
Introduction: Cholinesterases, from molecular complexity to non‐hydrolytic functions (2008) (4)
Butyrylcholinesterase and its synthetic C-terminal peptide confer in vitro suppression of amyloid fibril formation. (2008) (3)
Establishing Human Male and Female Models of Cholinergic Neurons via Neurokine-Mediated Differentiation of LA-N-2 and LA-N-5 Neuroblastoma Cells (2020) (3)
Rate of synthesis and concentration of specific mRNA sequences in cultured Chinese hamster ovary cells compared to liver cells. (1980) (3)
CHAPTER 1 – Biochemical and Biological Background (1993) (3)
Europe and the century of biomedical discovery and implementation. (2011) (3)
Improving poor in vitro transcription from G,C-rich genes. (1990) (3)
POLYNUCLEOTIDE PHOSPHORYLASE AS A PROBE FOR THE REGULATORY FUNCTION OF THE 3′-OH REGION OF mRNA AND VIRAL RNA IN TRANSLATION (1980) (3)
ACHE gene expression in human brain tumors involves alternative splicing and CREB-induced proliferative signals. (2006) (3)
Structure-function relationship studies in human cholinesterases reveal genomic origins for individual variations in cholinergic drug responses (1993) (3)
Prophylactic oligonucleotide-mediated enhancement of host acetylcholinesterase protects from organophosphate poisoning (2011) (3)
Building Bridges through Science (2017) (3)
HER-2 amplification but not butyrylcholinesterase multability reflects aggressiveness of European-originated ovarian tumors. (1995) (3)
Molecular biological search for human genes encoding cholinesterases (1987) (3)
Gulf War Syndrome, Psychological and Chemical Stressors* (2007) (2)
Correction: Gene Expression Differences in Peripheral Blood of Parkinson's Disease Patients with Distinct Progression Profiles (2017) (2)
Cerebrospinal fluid and blood profiles of transfer RNA fragments show age, sex and Parkinson’s disease-related changes (2022) (2)
High‐throughput morphometric and transcriptomic profiling uncovers composition of naïve and sensory‐deprived cortical cholinergic VIP/CHAT neurons (2022) (2)
Reply to “Cholinergic symptoms and Gulf War syndrome” (1995) (2)
Antisense Oligodeoxynucleotide Dependent Suppression of Acetylcholinesterase Expression Reduces Process Extension from Primary Mammalian Neurons (1998) (2)
Plasma acetylcholinesterase activity is correlated with intracerebral beta-amyloid load measured in vivo (2010) (2)
Corrigendum: Acute stress facilitates long-lasting changes in cholinergic gene expression (2015) (2)
The Role of MicroRNAs in Alzheimer's Disease (2013) (2)
Morphometric reconstructions atlas shows insult-driven plasticity in cortical VIP/ChAT interneurons (2020) (2)
Sex-related perturbations in schizophrenia and bipolar disorder brains reflect microRNA-mediated cholinergic/neurokine interactions (2019) (2)
Acetylcholine‐induced seizure‐like activity and modified cholinergic gene expression in chronically epileptic rats (2008) (2)
Proceedings: Role of the polyadenylic segment in the translation of globin messenger RNA. (1974) (2)
Distinct CholinomiR Blood Cell Signature as a Potential Modulator of the Cholinergic System in Women with Fibromyalgia Syndrome (2022) (2)
The Cholinotoxin AF64A Differentially Attenuates in Vitro Transcription of the Human Cholinesterase Genes (1995) (2)
Molecular neurotoxicology implications of acetylcholinesterase inhibition (2002) (2)
Tissue-specific processing and polarized compartmentalization of clone-produced cholinesterase in microinjectedXenopus oocytes (1989) (2)
MicroRNA regulators of cholinergic signaling link neuromuscular, cardiac and metabolic systems (2017) (2)
Molecular biology approach to the neurosciences (1984) (2)
The leukemic effect of anticholinesterases. (2001) (2)
A hypomorphic Stip1 allele reveals the requirement for chaperone networks in mouse development and aging (2018) (1)
Population Diversity of Point Mutations in the Human AChE and BCHE Genes Predicts Variable Responses to Anticholinesterase Drugs (1995) (1)
Clinical Implications of Cholinesterase Aberrations in Syndromes of Hemopoietic Cell Division (1992) (1)
Abstracts of the 15th Annual Meeting of the Israel Society for Neuroscience Eilat, Israel, December 3–5, 2006 (2006) (1)
Studying cholinergic features by transgenic manipulations of acetylcholinesterase gene expression (2006) (1)
Expression of nicotinic achetylcholine receptor subunits in ache-transgenic mice (2000) (1)
Molecular Dissection of Protein Domains Directing the Tissue Targeting of Acetylcholinesterase Isoforms (1997) (1)
Cholinergic Stress Signals Accompany MicroRNA-Associated Stereotypic Behavior and Glutamatergic Neuromodulation in the Prefrontal Cortex (2020) (1)
Genetic manipulations of cholinergic communication reveal trans-acting control mechanisms over acetylcholine receptors. (1997) (1)
Altered levels of variant cholinesterase transcripts contribute to the imbalanced cholinergic signaling in Alzheimer’s and Parkinson’s disease (2022) (1)
Cholinesterase modulations in patients with acute bacterial meningitis (2011) (1)
VALAPODYN: VALIDATED PREDICTIVE DYNAMIC MODEL OF COMPLEX INTRACELLULAR PATHWAYS RELATED TO CELL DEATH AND SURVIVAL (2007) (1)
Genomic Dissection Reveals Locus Response to Stress for Mammalian Acetylcholinesterase (2001) (1)
Antisense therapy directed against AChE attenuates light induced retinal damage in a rat model (2004) (1)
Deep brain stimulation modulates nonsense-mediated RNA decay in Parkinson’s patients leukocytes (2013) (1)
Transfer RNA fragments replace microRNA regulators of the cholinergic post-stroke immune blockade (2020) (1)
Cholinergic Stress Responses Facilitate the Molecular Mechanisms Underlying Granulocytosis. (2004) (1)
CORRIGENDUMduced seizure-like activity and modified cholinergic gene expression in chronically epileptic rats (2008) (1)
Reply: TDP-43 mutations increase HNRNP A1-7B through gain of splicing function. (2018) (1)
Stress and Neurodegeneration: Adding Insult to Injury? (2009) (1)
Microrna-Reacting Pseudogenes Control Cholinergic Signaling In Brain Neurons (2017) (1)
The Human Ache Locus Includes a Polymorphic Enhancer Domain 17KB Upstream from the Transcription Start Site (1998) (1)
Transient Alterations in the in Vivo Levels of Cholinesterase mRNAS Suggest Differential Adjustment to Cholinotoxic Stimuli (1995) (1)
Hippocampal Lipocalin 2: an emotional link between neurons and glia (2013) (1)
ANTISENSE OLIGONUCLEOTIDES SUPPRESSING EXPRESSION OF CHOLINESTERASE GENES MODULATE HEMATOPOIESIS IN VIVO AND EX VIVO (1995) (1)
Autism, Stress, and Chromosome 7 Genes (2002) (1)
Stress-associated “readthrough” acetylcholinesterase enhances hippocampal long-term potentiation and fear memory (2003) (1)
Modulating Cholinergic Neurotransmission Through Transgenic Overexpression of Human Cholinesterases (1994) (1)
Inducible and Constitutive β-Galactosidase Formation in Cells Recovering from Protein Synthesis Inhibition (1971) (1)
Cholinergic mechanisms--tenth international symposium. 1-5 September 1998, Arcachon, France. (1998) (1)
Letter by Shenhar-Tsarfaty et al regarding article, "Autonomic shift and increased susceptibility to infections after acute intracerebral hemorrhage". (2011) (1)
Cholinesterases in cellular and molecular neurobiology (1991) (1)
Cholinesterase Inhibitors: From Molecular Mechanisms of Action to Current and Future Prospects (2015) (1)
Integrative transcriptomics reveals sexually dimorphic microRNA control of the cholinergic/neurokine interface in schizophrenia and bipolar disorder (2019) (1)
Transgenic Engineering of Cholinesterases: Tools for Exploring Cholinergic Responses. (1998) (0)
Editorial Board (2011) (0)
PO11-305 ASSOCIATION OF SERUM PARAOXONASE WITH CAROTID ATHEROSCLEROSIS (2007) (0)
Acute stress induces long-lasting suppression of cholinergic neurotransmission (1997) (0)
Sex-specific declines in cholinergic-targeting tRNA fragments in the nucleus accumbens in Alzheimer’s disease (2023) (0)
Proceedings: Enzymatic acylation of histidine to tobacco mosaic virus RNA. (1975) (0)
Synthetic "antisense" oligonucleosides and pharmaceutical compositions containing them (1993) (0)
Cholinesterase modulations in patients with pneumococcal meningitis: 12AP3-8 (2008) (0)
Preface: Cholinergic mechanisms (2021) (0)
[Proceedings: Accelerated degradation of globin messenger RNA after removal of polyadenylic segment in Xenopus oocytes]. (1975) (0)
Elements of Molecular Neurobiology by C.U.M. Smith, John Wiley & Sons, 1989. £17.95 (v + 525 pages) ISBN 0471921246 (1990) (0)
The Multileveled Regulation of the Human Cholinesterase Genes and Their Protein Products (1993) (0)
Miriam M Salpeter (Mika) – biographical notes (2004) (0)
Cholinergic microRNA-132 sheds new light on the links between psychological stress and metabolic impairments (2017) (0)
Cholinoceptive properties of human primordial, preantral, and antral oocytes: In situ hybridization and biochemical evidence for expression of cholinesterase genes (2008) (0)
Alternative Exon 6 Directs Synaptic Localization of Recombinant Human Acetylcholinesterase in Neuromuscular Junctions of Xenopus laevis Embryos (1995) (0)
Postnatal enhancement of host acetylcholinesterase in developing AChE transgenic mice (1997) (0)
Abstracts of the 16th Annual Meeting of The Israel Society for Neuroscience Eilat, Israel, November 25–27, 2007 (2008) (0)
Regulation and Biosynthesis of Cholinesterases in the Human Brain (1986) (0)
On the topic of : " up-regulation of sodium currents boosts cortical input to striatal cholinergic interneurons in mouse models of Huntington ' s disease (2016) (0)
Proceedings: Role of the polyadenylic segment in the translation of globin messenger RNA. (1975) (0)
Less stress — more pressure? (1997) (0)
Vesicle-bound regulatory RNAs are associated with tissue aging (2021) (0)
Alexander George Karczmar (1917-2017). (2017) (0)
CHAPTER 3 – Scientific and Environmental Implications (1993) (0)
News Article of the Month , August 2017 ( Zohary ' s lab ) [ 1 ] Size constancy following long-term visual deprivation (2017) (0)
It is all about resolution. Meeting report based upon presentations at the 10th International Global BioMillennium 2006 symposium on molecular cell biology (Tbilisi, Georgia). (2007) (0)
Meet the Editorial Board (2015) (0)
Measuring cerebral acetylcholine esterase activity in Alzheimer dementia by PET functional parametric imaging. (2004) (0)
Biosynthesis and secretion of catal acetylcholinesterase in Xenopus ooc; microinjected with mRNA from r brain and from Torpedo electric org: (bioassay/half-life/scarce-enzyme expression) (2016) (0)
Acetylcholinesterase involvement in postnatal retinal development in the rat (2000) (0)
Synaptic Transmission—Cellular and Molecular Basis by Herbert Zimmermann. Thieme, Stuttgart, 1994, soft cover, ISBN 3‐13‐797401‐1, DM 58 (in U.S., Oxford, New York, soft cover, ISBN 019‐5210735, $29.95, hard cover, ISBN 019‐5210654, $55.00). (2002) (0)
77 Micro RNAs: a new therapeutic target in Alzheimer's disease (2012) (0)
Title : Modulation of neuronal resilience during aging by Hsp 70 / Hsp 90 / STI 1 chaperone system 1 (2019) (0)
Genomic Implications of Anticholinesterase Sensitivities (2011) (0)
Transient expression of human ache in developing embryos of Xenopus laevis (1992) (0)
[Medical aspects and structural implications of cholinesterase inhibitors]. (1992) (0)
Editorial: The molecular mechanisms of epilepsy and potential therapeutics (2022) (0)
Genetic Predisposition for Variable Response to Anticholinesterase Therapy Anticipated in Carriers of the Butyrylcholinesterase “Atypical” Mutation (1995) (0)
Inversely regulated immune-related processes mediate anxiety-obesity links in zebrafish (2023) (0)
[Gene amplification in tumors]. (1990) (0)
Antisense oligonucleotide against R isoform human acetylcholinesterase (ACHE-R) and their uses (2002) (0)
Hippocampal microRNA-132 mediates stress-inducible cognitive deficits through its acetylcholinesterase target (2012) (0)
CHAPTER 2 – Human Cholinesterase Genes and Their Expression (1993) (0)
Cholinesterases as Biomarkers for Parasympathetic Dysfunction and Inflammation-Related Disease (2013) (0)
The case of the human pink spider toxinase (1987) (0)
Human acetylcholinesterase gene is homologous to the ace locus in drosophila (1985) (0)
Quantitative dynamic proteome biology of anterior mice hippocampus (2009) (0)
Clinical and basic research observation implicate cholinesterases with cell division abnormalities (1992) (0)
II. Molecular Biological Approach to the Study of Cholinesterase Genes (1990) (0)
Studies on the Molecular Dissection of Human Cholinesterase Variants and their Genomic Origins. (1995) (0)
Modulation of neuronal resilience during aging by Hsp70/Hsp90/STI1 chaperone system (2019) (0)
Multilevel Approaches to AChE-Induced Impairments in Learning and Memory (1998) (0)
References / Subject Index (1990) (0)
Effects of physostigmine on microcirculatory alterations during experimental endotoxemia. (2011) (0)
CHOLINESTERASE GENE EXPRESSION AND SERUM LEVELS PREDICT 6 YEAR MAJOR ADVERSE CARDIAC EVENTS FOLLOWING CORONARY ANGIOGRAPHY (2016) (0)
Intensify3D: Normalizing signal intensity in large heterogenic image stacks (2018) (0)
Symposium 16: The role of hormoneregulated molecular modulators in traumatic responses Time: Saturday, 31/Aug/2019: 2:30pm–4:00pm Location: Cristalli Session Chair: Hermona Soreq Session Chair: Marla Sokolowski (2019) (0)
Brain Tumors Expression of Epidermal Growth Factor Receptors in Human Updated Version (2006) (0)
The Role of Human Antibodies toward Muscle Membrance Acetylcholinesterase in Neuromuscular Dysfunction a (1987) (0)
Genetic and Epigenetic Mechanisms Underlying Acute and Delayed Neurodegenerative Consequences of Stress and Anticholinesterase Exposure (2000) (0)
Non-coding RNAs and traumatic memories (2019) (0)
Role of the polyadenylate sequence in the stability of globin messenger RNA injected into Xenopus oocytes. (1977) (0)
Acetylcholinesterase promotes beta-amyloid plaque formation in vivo (2001) (0)
The Stress-Responding miR-132-3p Shows Evolutionarily Conserved Pathway Interactions (2017) (0)
Post-Transcriptional Regulation of Ontogenetically Modulated Proteins in the Nervous System (1984) (0)
S.17.03 Long non-coding pseudogene transcripts compete with mRNAs that share microRNA recognition elements with them in human brain neurons (2016) (0)
AChE and RACK1 Promote the Anti-Inflammatory Properties of Fluoxetine (2013) (0)
Coordinated regulation of gene expression from the acetylcholinesterase locus (1998) (0)
Issue Information (2021) (0)
Ribosomal protein L24 modulates mammalian microRNA processing and transfer RNA fragment production (2023) (0)
Proceedings: The polyadenylic segment of globin messenger RNA ensures its stability in vivo. (1975) (0)
Long-term modulations of cholinergic neurotransmission following chronic stress (1998) (0)
Altered activity of cholinergic enzymes in muscles and brain of the obese-diabetic (ob/ob) mouse (2004) (0)
III. Basic Research and Clinical Implications (1990) (0)
Neurotoxicological implications of the catalytic and non-catalytic functions of acetylcholinesterase (1998) (0)
Transgenic mammary gland expression of ‘readthrough’ human AChE: A model system for cholinesterase regulation in mammalian body fluids (1998) (0)
transActivation ofRatPhosphoenolpyruvate Carboxykinase (GTP) GeneExpression byMicro-Coinjectio n ofRatLivermRNA in Xenopuslaevis Oocytes (1989) (0)
Molecular cloning of human cholinesterase genes: potential applications in neurotoxicology. (1987) (0)
Dynamic proteomics of mice hippocampus to study apoptosis (2008) (0)
Acetylcholinesterase and plants An inquiry to plant biochemistry and a biotechnology application (2002) (0)
Antisense Approach to Isoform-Specific Blockade of Acetylcholinesterase (2001) (0)
Victims of war: Hair cortisol and DHEA and their associations with trauma sequelae and resilience in adolescents living in the west bank (2019) (0)
Human acetylcholinesterase transgenic mice show elevated muscle expression and brain specific silencing (1998) (0)
Non-coding RNAs: An integrative biology hope for anxiety-related syndromes (2016) (0)
Structure-Function Relationships, In Vivo Mutability and Gene Amplification in Human Cholinesterases, Targets for Organophosphorous Poisons (1991) (0)
Procede et kit d'evaluation de l'anxiete ou de disposition a l'anxiete chez un sujet (2004) (0)
Biological underpinnings of sex differences in neurological disorders. (2022) (0)
It is all about resolution (2007) (0)
A SYSTEMS BIOLOGY APPROACH TARGETING NEUROLOGICAL DISEASE- FROM GENOMICS TO IN SILICO PREDICTIVE MODELS (2007) (0)
Growing up during the Israeli-Palestinian conflict: The interplay of sense of coherence and the psychological and psychoendocrine consequences of traumatic stress (2019) (0)
Transgenic Biosensors for Organophosphorous Poisoning and the Protective Efficacy of Defense Agents Toward an Engineered Cholinesterase Decoy (1993) (0)
Labeling Acetyl- and Butyrylcholinesterase Using Semiconductor Nanocrystals for Biological Applications (2013) (0)
S.05.01 Single nucleotide polymorphisms co-modulating anxiety and metabolic disorders (2019) (0)
Developing predictive dynamic models of complex intracellular networks for neurological disease (2008) (0)
AChE Gene Expression under Functional Deficits Induced by Light Stress to the Rat Retina (2002) (0)
Central and Peripheral Consequences of Cholinergic Imbalance in Alzheimer’s Disease (1997) (0)
The XII International Symposium on Cholinergic Mechanisms (2006) (0)
Amplification and Mutagenesis of the Acetylcholinesterase and Butyrylcholinesterase Genes in Primary Human Tumors (2020) (0)
The Non-Catalytic Role and Complex Management of Acetylcholinesterase in the Mammalian Brain Call for RNA-Based Therapies (1998) (0)
Antisense Intervention with Cholinergic Impairments Associated with Neurodegenerative Disease (2002) (0)
VALAPODYN: A new systems biology approach to develop predictive dynamic models of complex intracellular networks for neurological disease (2008) (0)
29 Elevated acetylcholine release in the hippocampus of transgenic mice expressing the human acetylcholinesterase (1998) (0)
Fear, Fat, and Genes: New Answers to Old Questions (2019) (0)
Acetylcholinesterase activity in the cerebrospinal fluid of dogs with seizures. (2013) (0)
330: Advanced Bioscavengers for the Emergency Treatment of Nerve Agent/Pesticide Poisoning (2008) (0)
Macromolecular complexes in Alzheimer’s disease pathogenesis : partners of acetylcholinesterase (2006) (0)
Structure-function relationships in natural and recombinant alternative forms of human CHE (1992) (0)
HIGHER MICRORNA-132 IS ASSOCIATED WITH BLOOD PRESSURE AND LIVER STEATOSIS IN OBESE INDIVIDUALS (2018) (0)
Deregulated microRNA-132-3p in Alzheimer's disease (2014) (0)
Deep transcriptome sequencing identifies disease-associated miRNA-alternative splicing networks in Parkinson's leukocytes (2013) (0)
Genetic Manipulations of Catalytic and Non-Catalytic Functions of Human Cholinesterases (1998) (0)
mRNA Modulations in Stress and Aging (2008) (0)
Transgenic and antisense manipulations of impairments in cholinergic balance (2008) (0)
Proceedings: Effects of cycloheximide on virus DNA replication in an inducible line of polyomatransformed rat cells. (1975) (0)
Overexpression of nitzin, a novel member of the ezrin-radixin-moesin (ERM) protein family is associated with deficient neurite extension under antisense suppression of acetylcholinesterase in PC12 cells (1997) (0)
The Use of Gapmers for In Vivo Suppression of Hepatic mRNA Targets. (2020) (0)
Biosynthesis and secretion of catalytically active acetylcholinesterase in Xenopus oocytes microinjected with mRNA from rat (2003) (0)
[In-situ hybridization on chorionic villi chromosomes]. (1989) (0)
Catalytic and Non-Catalytic Activities of Acetylcholinesterase Implied from Transgenic ACHE Expression in Vertebrates (1997) (0)
Fifth IBRO World Congress of Neuroscience, Jerusalem, Israel, July 11-15, 1999 (1999) (0)
STRUCTURE-FUNCTION RELATIONSHIP STUDIES IN HUMAN CHOLINESTERASES AS AN APPROACH FOR EVALUATING POTENTIAL PHARMACOTHERAPEUTIC AND/OR TOXICITY EFFECTS OF CHOLINERGIC DRUGS (1991) (0)
Molecular forms and induction of acetylcholinesterase in human leukaemic cells (1985) (0)
SINGLE NUCLEOTIDE POLYMORPHISMS IN THE GENES ENCODING AChE AND ITS miR-608 REGULATOR CO-MODULATE ANXIETY AND BLOOD PRESSURE (2018) (0)
‘Readthrough’ acetylcholinesterase and cholinergic neurotransmission (2004) (0)
DYNAMIC PROTEOME ANALYSIS OF ANTERIOR MICE HIPPOCAMPUS (2010) (0)
Key domains in human cholinesterases disclosed using microinjected xenopus oocytes (1992) (0)
A peptide cleaved from the stress associated variant form of acetylcholinesterase modulates hematopoiesis (2000) (0)
Stress Reactions Orchestrate Parasympathetic Functioning and Inflammation Under Diverse Cholinergic Manipulations (2017) (0)
Molecular Biological Studies on the Biogenesis of Human Cholinesterases In Vivo and as Directed by Cloned Cholinesterase DNA Sequences (1989) (0)
Title Page / Contents / Acknowledgements (1990) (0)
Serum acetylcholinesterase decline predicts major adverse cardiac events following coronary angiography (2013) (0)
Chapter 4:The Bimodal Features of Butyrylcholinesterase in Cholinergic Neurotransmission and Amyloid Suppression (2010) (0)

This paper list is powered by the following services:

Other Resources About Hermona Soreq

en.wikipedia.org

What Schools Are Affiliated With Hermona Soreq?

Hermona Soreq is affiliated with the following schools:

Image Attributions

Image Source for Hermona Soreq